Voxsanity

Who may be able to join

Who might be able to join this trial:

You have been diagnosed with type 2 diabetes for at least 12 months
Your body mass index (BMI) is 35.0 or below (BMI is a measure based on your height and weight)

Who may not be able to join:

You have donated blood or plasma in the past month, or donated more than 500 mL (about a pint) of blood in the past 3 months
You smoke more than 5 cigarettes a day, or the equivalent amount using other tobacco products
You are not able or willing to stop smoking and avoid nicotine products (such as nicotine gum or nicotine patches) during the time you would need to stay at the trial site

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status

Completed

Phase

Phase 1

Sponsor

Novo Nordisk A/S

Registry

clinicaltrials_gov

Start date

1 June 2010

Est. completion

1 November 2010

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Area under the glucose infusion rate curve from 0-24 hours at steady state

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov